The Trump administration reportedly is bothered by the $18.9 billion trade deficit with Switzerland, which is mainly driven by pharmaceuticals.
While the tariffs do not appear to be an immediate threat, they could potentially affect Swiss pharma giants Novartis and Roche and other manufacturers that produce drugs in Switzerland, like Merck and Biogen.
Read the full report here.
More articles on pharmacy:
Novant Health to open health clinics inside Walgreens
GlaxoSmithKline recalls prescription heartburn drug globally
BIO CEO to step down at the end of 2020
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
